Molecular mechanisms of schizophrenia - PubMed (original) (raw)
Review
doi: 10.1159/000110430.
Affiliations
- PMID: 17982252
- DOI: 10.1159/000110430
Free article
Review
Molecular mechanisms of schizophrenia
Undine E Lang et al. Cell Physiol Biochem. 2007.
Free article
Abstract
Schizophrenia is a complex disorder, where family, twin and adoption studies have been demonstrating a high heritability of the disease and that this disease is not simply defined by several major genes but rather evolves from addition or potentiation of a specific cluster of genes, which subsequently determines the genetic vulnerability of an individual. Linkage and association studies suggest that a genetic vulnerablility, is not forcefully leading to the disease since triggering factors and environmental influences, i.e. birth complications, drug abuse, urban background or time of birth have been identified. This has lead to the assumption that schizophrenia is not only a genetically defined static disorder but a dynamic process leading to dysregulation of multiple pathways. There are several different hypothesis based on several facets of the disease, some of them due to the relatively well-known mechanisms of therapeutic agents. The most widely considered neurodevelopmental hypothesis of schizophrenia integrates environmental influences and causative genes. The dopamine hypothesis of schizophrenia is based on the fact that all common treatments involve antidopaminergic mechanisms and genes such as DRD2, DRD3, DARPP-32, BDNF or COMT are closely related to dopaminergic system functioning. The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3). Correspondingly, GABA has been proposed to modulate the pathophysiology of the disease which is represented by the involvement of genes like GABRA1, GABRP, GABRA6 and Reelin. Moreover, several genes implicating immune, signaling and networking deficits have been reported to be involved in the disease, i.e. DISC1, RGS4, PRODH, DGCR6, ZDHHC8, DGCR2, Akt, CREB, IL-1B, IL-1RN, IL-10, IL-1B. However, molecular findings suggest that a complex interplay between receptors, kinases, proteins and hormones is involved in schizophrenia. In a unifying hypothesis, different cascades merge into another that ultimately lead to the development of symptoms adherent to schizophrenic disorders.
Similar articles
- eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia?
Carter CJ. Carter CJ. Schizophr Bull. 2007 Nov;33(6):1343-53. doi: 10.1093/schbul/sbm007. Epub 2007 Feb 27. Schizophr Bull. 2007. PMID: 17329232 Free PMC article. Review. - Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance.
Cherlyn SY, Woon PS, Liu JJ, Ong WY, Tsai GC, Sim K. Cherlyn SY, et al. Neurosci Biobehav Rev. 2010 May;34(6):958-77. doi: 10.1016/j.neubiorev.2010.01.002. Epub 2010 Jan 7. Neurosci Biobehav Rev. 2010. PMID: 20060416 Review. - Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia.
Petryshen TL, Middleton FA, Tahl AR, Rockwell GN, Purcell S, Aldinger KA, Kirby A, Morley CP, McGann L, Gentile KL, Waggoner SG, Medeiros HM, Carvalho C, Macedo A, Albus M, Maier W, Trixler M, Eichhammer P, Schwab SG, Wildenauer DB, Azevedo MH, Pato MT, Pato CN, Daly MJ, Sklar P. Petryshen TL, et al. Mol Psychiatry. 2005 Dec;10(12):1074-88, 1057. doi: 10.1038/sj.mp.4001739. Mol Psychiatry. 2005. PMID: 16172613 Clinical Trial. - Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia.
Nicodemus KK, Kolachana BS, Vakkalanka R, Straub RE, Giegling I, Egan MF, Rujescu D, Weinberger DR. Nicodemus KK, et al. Hum Genet. 2007 Feb;120(6):889-906. doi: 10.1007/s00439-006-0257-3. Epub 2006 Sep 28. Hum Genet. 2007. PMID: 17006672 - Major affective disorders and schizophrenia: a common molecular signature?
Van Den Bogaert A, Del-Favero J, Van Broeckhoven C. Van Den Bogaert A, et al. Hum Mutat. 2006 Sep;27(9):833-53. doi: 10.1002/humu.20369. Hum Mutat. 2006. PMID: 16917879 Review.
Cited by
- GRIN2A mutation is a novel indicator of stratifying beneficiaries of immune checkpoint inhibitors in multiple cancers.
Li GX, Chang RZ, Liu TT, Jin GN, Lu K, Yong TY, Li Z, Liu JH, Zhang B, Zhang WG, Ding ZY. Li GX, et al. Cancer Gene Ther. 2024 Apr;31(4):586-598. doi: 10.1038/s41417-024-00730-6. Epub 2024 Jan 24. Cancer Gene Ther. 2024. PMID: 38267623 - Zinc and Central Nervous System Disorders.
Wang B, Fang T, Chen H. Wang B, et al. Nutrients. 2023 Apr 29;15(9):2140. doi: 10.3390/nu15092140. Nutrients. 2023. PMID: 37432243 Free PMC article. Review. - Toxoplasma gondii induced cognitive impairment in rats via dysregulation of dopamine receptors and indoleamine 2,3 dioxygenase.
Wana MN, Watanabe M, Chiroma SM, Unyah NZ, Abdullahi SA, Nordin S, Basir R, Mohd Moklas MA, Majid RA. Wana MN, et al. Heliyon. 2023 Mar 9;9(3):e14370. doi: 10.1016/j.heliyon.2023.e14370. eCollection 2023 Mar. Heliyon. 2023. PMID: 36950587 Free PMC article. - In silico prediction and in vivo testing of promoters targeting GABAergic inhibitory neurons.
Niibori Y, Duba-Kiss R, Bruder JT, Smith JB, Hampson DR. Niibori Y, et al. Mol Ther Methods Clin Dev. 2023 Feb 4;28:330-343. doi: 10.1016/j.omtm.2023.01.007. eCollection 2023 Mar 9. Mol Ther Methods Clin Dev. 2023. PMID: 36874244 Free PMC article. - Prenatal Zinc Supplementation Ameliorates Hippocampal Astrocytes Activation and Inflammatory Cytokines Expression Induced by Lipopolysaccharide in a Rat Model of Maternal Immune Activation.
Savareh E, Davoodian N, Mousaviyan R, Ghasemi-Kasman M, Atashabparvar A, Eftekhar E. Savareh E, et al. Basic Clin Neurosci. 2022 May-Jun;13(3):335-347. doi: 10.32598/bcn.2021.3361.1. Epub 2022 May 1. Basic Clin Neurosci. 2022. PMID: 36457888 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous